SC 13G/A: Aclaris Therapeutics, Inc.
Ticker: ACRS · Form: SC 13G/A · Filed: Jul 8, 2024 · CIK: 1557746
| Field | Detail |
|---|---|
| Company | Aclaris Therapeutics, INC. (ACRS) |
| Form Type | SC 13G/A |
| Filed Date | Jul 8, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Aclaris Therapeutics, Inc..
Risk Assessment
Risk Level: low
FAQ
What type of filing is this?
This is a SC 13G/A filing submitted by Aclaris Therapeutics, INC. (ticker: ACRS) to the SEC on Jul 8, 2024.
What is the risk level of this SC 13G/A filing?
This filing has been assessed as low risk.
Where can I view the full SC 13G/A filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on July 8, 2024 regarding Aclaris Therapeutics, Inc. (ACRS).